Brief Interview by Doctor May Cut Cannabis Use in Some Youth

This article originally appeared here.
Share this content:
Brief Interview by Doctor May Cut Cannabis Use in Some Youth
Brief Interview by Doctor May Cut Cannabis Use in Some Youth

MONDAY, March 20, 2017 (HealthDay News) -- A brief intervention conducted by general practitioners could reduce cannabis use among some younger users, according to a study published in the March/April issue of the Annals of Family Medicine.

Catherine Laporte, M.D., Ph.D., from the University Clermont in France, and colleagues conducted a cluster randomized trial involving 77 general practitioners in France to test the efficacy of a brief intervention among cannabis users aged 15 to 25 years. The intervention comprised an interview designed according to the feedback, responsibility, advice, menu, empathy, self-efficacy model, while the control condition was routine care. Two hundred sixty-one young cannabis users were screened and followed.

The researchers found that among all users there was no significant between-group difference in the median number of joints smoked per month after one year (17.5 versus 17.5; P = 0.13); however, among non-daily users there was a difference in favor of the intervention (3.0 versus 10.0; P = 0.01). In terms of the number of joints smoked, the intervention correlated with a more favorable change from baseline after six months (−33.3 versus 0 percent; P = 0.01). The intervention correlated with smoking of fewer joints per month among users younger than 18 years (12.5 versus 20.0; P = 0.04).

"Our results do, however, strongly support use of brief interventions for users who are younger than age 18 and for moderate, non-daily users," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »